Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 5
1948 1
1949 3
1950 7
1951 6
1952 5
1953 9
1954 6
1955 7
1956 9
1957 11
1958 6
1959 12
1960 16
1961 11
1962 23
1963 42
1964 82
1965 59
1966 46
1967 73
1968 102
1969 132
1970 125
1971 186
1972 238
1973 294
1974 351
1975 321
1976 309
1977 358
1978 329
1979 316
1980 345
1981 349
1982 340
1983 355
1984 391
1985 391
1986 383
1987 392
1988 359
1989 378
1990 363
1991 405
1992 397
1993 424
1994 380
1995 356
1996 350
1997 364
1998 352
1999 308
2000 355
2001 327
2002 334
2003 419
2004 282
2005 293
2006 319
2007 255
2008 262
2009 245
2010 312
2011 303
2012 283
2013 314
2014 319
2015 250
2016 269
2017 247
2018 286
2019 232
2020 247
2021 271
2022 253
2023 229
2024 69

Text availability

Article attribute

Article type

Publication date

Search Results

17,239 results

Results by year

Filters applied: . Clear all
Page 1
Digoxin: Pharmacology and toxicology-A review.
Patocka J, Nepovimova E, Wu W, Kuca K. Patocka J, et al. Environ Toxicol Pharmacol. 2020 Oct;79:103400. doi: 10.1016/j.etap.2020.103400. Epub 2020 May 7. Environ Toxicol Pharmacol. 2020. PMID: 32464466 Review.
Digoxin is a cardiac glycoside used as drug in case of heart problems, including congestive heart failure, atrial fibrillation or flutter, and certain cardiac arrhythmias. It has a very narrow therapeutic window of the medication. Digoxin is toxic substance with wel
Digoxin is a cardiac glycoside used as drug in case of heart problems, including congestive heart failure, atrial fibrillation or flu
Digoxin targets low density lipoprotein receptor-related protein 4 and protects against osteoarthritis.
Wang KD, Ding X, Jiang N, Zeng C, Wu J, Cai XY, Hettinghouse A, Khleborodova A, Lei ZN, Chen ZS, Lei GH, Liu CJ. Wang KD, et al. Ann Rheum Dis. 2022 Apr;81(4):544-555. doi: 10.1136/annrheumdis-2021-221380. Epub 2021 Dec 1. Ann Rheum Dis. 2022. PMID: 34853001 Free PMC article.
LRP4 was isolated as a novel target of digoxin, and deletion of LRP4 abolished digoxin's regulations of chondrocytes. CONCLUSIONS: These findings not only provide new insights into the understanding of digoxin's chondroprotective action and unde …
LRP4 was isolated as a novel target of digoxin, and deletion of LRP4 abolished digoxin's regulations of chondrocytes. C …
Digoxin.
Lutterbeck PM, Levy RH, Lindenbaum J, Mellow MH, Blackstone MO, Butler VP Jr. Lutterbeck PM, et al. N Engl J Med. 1972 Mar 23;286(12):666-7. doi: 10.1056/NEJM197203232861217. N Engl J Med. 1972. PMID: 5060498 No abstract available.
Role of Digoxin in Atrial Fibrillation.
Scalese MJ, Salvatore DJ. Scalese MJ, et al. J Pharm Pract. 2017 Aug;30(4):434-440. doi: 10.1177/0897190016642361. Epub 2016 Apr 10. J Pharm Pract. 2017. PMID: 27067743 Review.
Despite digoxin's extensive history, recent literature has cast doubt on the efficacy and safety of this medication in the population with AF. ...The potential risk of mortality must be weighed against the expected benefits of digoxin use to make individualiz …
Despite digoxin's extensive history, recent literature has cast doubt on the efficacy and safety of this medication in the pop …
Medigoxin.
[No authors listed] [No authors listed] Lancet. 1978 Nov 25;2(8100):1135. Lancet. 1978. PMID: 82691 No abstract available.
Digoxin protects against intervertebral disc degeneration via TNF/NF-kappaB and LRP4 signaling.
Meng Q, Liu K, Liu Z, Liu J, Tian Z, Qin S, Wei J, Cheng L. Meng Q, et al. Front Immunol. 2023 Sep 18;14:1251517. doi: 10.3389/fimmu.2023.1251517. eCollection 2023. Front Immunol. 2023. PMID: 37790932 Free PMC article.
METHODS: We exploited a rat needle model to investigate digoxin's role in intervertebral disc degeneration in vivo. Safranin O staining was used to measure cartilaginous tissue in the intervertebral disc. ...Digoxin might also work as an alternative for other …
METHODS: We exploited a rat needle model to investigate digoxin's role in intervertebral disc degeneration in vivo. Safranin O …
Digoxin--issues and controversies.
Soldin SJ. Soldin SJ. Clin Chem. 1986 Jan;32(1 Pt 1):5-12. Clin Chem. 1986. PMID: 3510096 Review.
This review deals briefly with the clinical pharmacology of digoxin and reviews in some depth the problems inherent in methods of digoxin measurement. Digoxin-like factors (materials that cross react in digoxin immunoassays) are discussed, and some cur …
This review deals briefly with the clinical pharmacology of digoxin and reviews in some depth the problems inherent in methods of …
Digoxin.
Colaizzi JL. Colaizzi JL. J Am Pharm Assoc. 1977 Oct;17(10):635-8. doi: 10.1016/s0003-0465(16)34485-8. J Am Pharm Assoc. 1977. PMID: 908820 No abstract available.
Digoxin--a redundant drug in congestive cardiac failure.
Poole-Wilson PA, Robinson K. Poole-Wilson PA, et al. Cardiovasc Drugs Ther. 1989 Jan;2(6):733-41. doi: 10.1007/BF00133201. Cardiovasc Drugs Ther. 1989. PMID: 2488085 Review.
Digoxin is properly used to control the heart rate in patients in atrial fibrillation. ...Alternative and safer therapies have been shown to be equal or superior to digoxin....
Digoxin is properly used to control the heart rate in patients in atrial fibrillation. ...Alternative and safer therapies have been s
Computer-assisted digoxin therapy.
Peck CC, Sheiner LB, Martin CM, Combs DT, Melmon KL. Peck CC, et al. N Engl J Med. 1973 Aug 30;289(9):441-6. doi: 10.1056/NEJM197308302890902. N Engl J Med. 1973. PMID: 4763409 Clinical Trial. No abstract available.
17,239 results
You have reached the last available page of results. Please see the User Guide for more information.